PhD Inorganic Chemistry – University of Bordeaux, France
Master’s Foods & Nutrition – University of Utah, Salt Lake City
Registered Dietitian – Currently licensed
Awards
Silver Stevie® Award for “Best New Product – Consumer Products” in the 17th annual American Business Awards® for LifeVantage TrueScience® Hair Care System. June 2019
Bronze Stevie® Award for “Best New Product – Consumer Products” in the 17th annual American Business Awards® for LifeVantage Vitality Stack. October 2018
Small Business Investigator Award – 3/1/93-8/15/93
NIH Award No 1-R43-CA59074-01
“Effect of Enteral formulas on Cyclophosphamide and 5-Fluorouracil Toxicity”.
Research Grant Fellowship – 9/91-6/92
University of Utah.
“Effect of Enteral formulas on Methotrexate Toxicity”.
Outstanding Graduate Student in Academics – 1992
Publications and Presentations
N. Chevreau. US 9,889,171 B2 Topical compositions and methods for reducing oxidative stress. February 13, 2018.
N. Chevreau. Protandim® treatment causes reversible nuclear translocation of Nrf2 and activation of the antioxidant response element. J. Intern. Soc. Antioxidants. 3 (3). Jan 2017. DOI 10.18143/JISANH_v3i3_1186.
N. Chevreau. US 9,289374 B2 Topical compositions and methods for reducing oxidative stress. March 22, 2016.
A.C. Benichou, M. Armanet, A. Bussière, N. Chevreau, JM Cardot, and J. Tétard. A proprietary blend of quail egg for the attenuation of nasal provocation with a standardized allergenic challenge: a randomized, double-blind, placebo-controlled study. Food Science & Nutrition, Published July 20, 2014.
J. Ehrenkranz, N. Chevreau, S. Alder, and J. Roth. Oral phlorizin, an inhibitor of active glucose transport, blunts the postprandial glucose and insulin rise in humans. P3-411. ENDO 05, June 6, 2005, San Diego, CA.
N. Chevreau, P. Anthony and K. Kessinger. Managing Hyperemesis Gravidarum with Home Parenteral Nutrition: Treatment Parameters and Clinical Outcomes. Infusion. 5(8), 22-28, May 1999.
N. Chevreau, K. Kessinger and P. Anthony: Incidence of IV lipid intolerance in Hyperemesis Gravidarum on Home TPN. Presented at the Aspen 23rd Clinical Congress. Jan 31-Feb 3, 1999.
N. Chevreau: Pregnancy outcome of patients with Hyperemesis Gravidarum receiving TPN. Presented at the ASPEN 22nd Clinical Congress. Jan 18-21, 1998.
B. Meierhofer and N. Chevreau: Subcutaneous Reglan therapy for nausea/vomiting in Hyperemesis Gravidarum. Presented at the NAVAN National conference. Philadelphia, Sept 17-20, 1997.
N. Chevreau and M. Funk-Archuleta: Effect of enteral formulas on methotrexate toxicity. Nutrition and Cancer. 23:2, 185-204, 1995.
N. Chevreau, Y. Wang and M. Funk-Archuleta: Effect of diets on 5-fluorouracil and cyclophosphamide toxicity. Nutrition and Cancer. 23:2, 205-220, 1995.
Y. Wang, M. Funk, K. Garleb, and N. Chevreau: The effect of fiber source in enteral products on fecal weight, mineral balance, and growth rate in rats. JPEN. 18:4, 340-345, 1994.
N. Chevreau and M. Funk-Archuleta: Effect of enteral formulas on methotrexate toxicity. Abstract presented at FASEB, April 1994.
J.K. Weeks, N. Chevreau, Jared Lee Sommer, and Joel Sommer: The manufacture of high Tc superconducting composite wires. Phase II SBIR Final Report. Naval Surface Warfare Center Award No N60921-90-C-0106, May 2, 1992.
J.K. Weeks, N. Chevreau, and R.L. Seeley: Graphite reinforced copper alloys for fusion reactors application. Phase II SBIR Final Report. DOE Award No DE-AC02-87ER80504, October 16, 1991.
J.K. Weeks, and N. Chevreau: Titanium nitride reaction mechanisms. Phase II SBIR Final Report. NSF Award No ISI-8701749, Sept. 30, 1991.
J.K. Weeks, N. Chevreau: Copper infiltrated graphite for improved brazed joints. Fusion Technology. 19, 1772, 1991.
J.K. Weeks, N. Chevreau, and R. Seeley: Copper infiltrated graphite for improved brazed joints. Phase I SBIR Final Report, DOE Award No DE-AC02-89ER80789, April 24, 1990.
J.K. Weeks, C. Gensse, and N. Chevreau: Graphite Reinforced Aluminum Composite by Liquid Metal Infiltration. Phase I SBIR Final Report, NSWC Award No N60921-89-C-0176, February 15, 1990.
J.K. Weeks, N. Chevreau: Silicon Nitride. Phase I SBIR Final Report, NSF Award No ISI-8760932, July 31, 1988.
N. Chevreau, and D. Johnson D.: Preparation and physical properties of BiMO6S8 and SbMO6S8. J. Solid State Chemistry, 61, 347, 1986.
J.L. Soubeyroux J.L., and N. Chevreau: Neutron diffraction in the study of Sr0.5La1.5Li0.5Fe0.504. J. Solid State Chem., 50, 2977, 1983.
J.L. Soubeyroux, N. Chevreau, B. Buffat, and G. Demazeau: Magnetic properties of oxides containing six-coordinated iron (IV) and (V). Physica, 120B, 227 1983.
G. Demazeau, N. Chevreau, and B. Buffat: Coexistence of six-coordinated high spin iron (IV) and low spin Ni (III) in an oxygen lattice. C.R. Acad. SC. Paris, 295, 661, 1982.
Find Nathalie Online
“Scientific support and regulatory guidance to get nutraceutical finished products or raw materials ready for the US market.”-Nathalie Chevreau